Abanilla, Baby Girl .
HRN: 26-58-71 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/23/2025
AMPICILLIN 250MG (VIAL)
03/23/2025
03/30/2025
IV
190mg
Q12
Potentially Septic Newborn
Waiting Final Action
Indication: Prophylaxis Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes